Access the full text.
Sign up today, get DeepDyve free for 14 days.
A. Beaudet, L. Tsui (1993)
A suggested nomenclature for designating mutationsHuman Mutation, 2
P. Fanen, N. Ghanem, M. Vidaud, C. Besmond, Josiane Martin, B. Costes, F. Plassa, M. Goossens (1992)
Molecular characterization of cystic fibrosis: 16 novel mutations identified by analysis of the whole cystic fibrosis conductance transmembrane regulator (CFTR) coding regions and splice site junctions.Genomics, 13 3
(2000)
An unusual deletion/insertion mutation of the CFTR gene in German, Turkish and Jordanian cystic ®brosis patients
L. Cremonesi, M. Ferrari, E. Belloni, C. Magnani, M. Seia, P. Ronchetto, M. Rady, M. Russo, G. Romeo, M. Devoto (1992)
Four new mutations of the CFTR gene (541delC, R347H, R352Q, E585X) detected by DGGE analysis in Italian CF patients, associated with different clinical phenotypesHuman Mutation, 1
J. Zieleński, R. Rozmahel, D. Bozon, B. Kerem, Z. Grzelczak, J. Riordan, J. Rommens, Lap-Chee Tsui (1991)
Genomic DNA sequence of the cystic fibrosis transmembrane conductance regulator (CFTR) gene.Genomics, 10 1
T. Ivaschenko, M. White, M. Dean, V. Baranov (1991)
A deletion of two nucleotides in exon 10 of the CFTR gene in a Soviet family with cystic fibrosis causing early infant death.Genomics, 10 1
W. Highsmith, L. Burch, Z. Zhou, J. Olsen, T. Boat, A. Spock, Jack Gorvoy, L. Quittel, K. Friedman, L. Silverman (1994)
A novel mutation in the cystic fibrosis gene in patients with pulmonary disease but normal sweat chloride concentrations.The New England journal of medicine, 331 15
M. Kilinç, V. Ninis, E. Dağlı, M. Demirkol, F. Ozkinay, Zeliha Arikan, O. Cogulu, G. Hüner, F. Karakoc, A. Tolun (2002)
Highest heterogeneity for cystic fibrosis: 36 mutations account for 75% of all CF chromosomes in Turkish patients.American journal of medical genetics, 113 3
T. Bienvenu, C. Beldjord, J. Chelly, N. Fonknechten, D. Hubert, D. Dusser, J. Kaplan (1996)
Analysis of Alternative Splicing Patterns in the Cystic Fibrosis Transmembrane Conductance Regulator Gene Using mRNA Derived from Lymphoblastoid Cells of Cystic Fibrosis PatientsEuropean Journal of Human Genetics, 4
A. Augarten, Y. Yahav, J. Laufer, A. Szeinberg, J. Dor, S. Mashiach, I. Madgar, D. Halle, Eran Gazit, B. Kerem (1994)
Congenital bilateral absence of vas deferens in the absence of cystic fibrosisThe Lancet, 344
M. Lira, M. Benetazzo, M. Marzari, C. Bombieri, F. Belpinati, C. Castellani, G. Cavallini, G. Mastella, P. Pignatti (2000)
High frequency of cystic fibrosis transmembrane regulator mutation L997F in patients with recurrent idiopathic pancreatitis and in newborns with hypertrypsinemia.American journal of human genetics, 66 6
V. Mak, J. Zieleński, Lap-Chee Tsui, P. Durie, Armand Zini, S. Martin, T. Longley, Keith Jarvi (1999)
Proportion of cystic fibrosis gene mutations not detected by routine testing in men with obstructive azoospermia.JAMA, 281 23
Shalender Bhasin, Kun Ma, Indranil Sinha, Michael Limbo, Wayne Taylor, B. Salehian (1998)
The genetic basis of male infertility.Endocrinology and metabolism clinics of North America, 27 4
T. Dörk, F. Mekus, K. Schmidt, J. Boßhammer, R. Fislage, T. Heuer, Violetta Dziadek, T. Neumann, N. Kälin, U. Wulbrand, B. Wulf, H. Hardt, Günther Maaß, B. Tümmler (1994)
Detection of more than 50 different CFTR mutations in a large group of German cystic fibrosis patientsHuman Genetics, 94
and sequenced using the primer pair 5¢-GTCCTC-CAGCGTTGCCAACTGG-3¢ and 5¢-CAACGCTGGCCTTTTCC-AGAGG-3¢ (annealing at 62°C)
B. Costes, E. Girodon, N. Ghanem, E. Flori, A. Jardin, J. Soufir, M. Goossens (1995)
Frequent Occurrence of the CFTR Intron 8 (TG)n 5T Allele in Men with Congenital Bilateral Absence of the Vas DeferensEuropean Journal of Human Genetics, 3
J. Zieleński, Lap-Chee Tsui (1995)
Cystic fibrosis: genotypic and phenotypic variations.Annual review of genetics, 29
R. Oates, J. Amos (1994)
The genetic basis of congenital bilateral absence of the vas deferens and cystic fibrosis.Journal of andrology, 15 1
C. Chu, B. Trapnell, S. Curristin, G. Cutting, R. Crystal (1993)
Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNANature Genetics, 3
Gene Yeo, C. Burge (2003)
Maximum entropy modeling of short sequence motifs with applications to RNA splicing signalsJournal of computational biology : a journal of computational molecular cell biology, 11 2-3
M. Audrézet, B. Mercier, H. Guillermit, I. Quéré, C. Verlingue, G. Rault, C. Férec (1993)
Identification of 12 novel mutations in the CFTR gene.Human molecular genetics, 2 1
M. Macek, Alice Macková, A. Hamosh, B. Hilman, R. Selden, G. Lucotte, K. Friedman, M. Knowles, B. Rosenstein, G. Cutting (1997)
Identification of common cystic fibrosis mutations in African-Americans with cystic fibrosis increases the detection rate to 75%.American journal of human genetics, 60 5
S. Larriba, L. Bassas, J. Giménez, M. Ramos, A. Segura, V. Nunes, X. Estivill, T. Casals (1998)
Testicular CFTR splice variants in patients with congenital absence of the vas deferens.Human molecular genetics, 7 11
T. Dörk, B. Dworniczak, C. Aulehla‐Scholz, D. Wieczorek, I. Böhm, A. Mayerová, H. Seydewitz, E. Nieschlag, D. Meschede, J. Horst, H. Pander, Herbert Sperling, F. Ratjen, E. Passarge, J. Schmidtke, M. Stuhrmann (1997)
Distinct spectrum of CFTR gene mutations in congenital absence of vas deferensHuman Genetics, 100
J. Hull, S. Shackleton, A. Harris (1994)
Analysis of mutations and alternative splicing patterns in the CFTR gene using mRNA derived from nasal epithelial cells.Human molecular genetics, 3 7
V. Dumur, R. Gervais, J. Rigot, E. Delomel-Vinner, B. Decaestecker, J. Lafitte, P. Roussel (2004)
Congenital bilateral absence of the vas deferens (CBAVD) and cystic fibrosis transmembrane regulator (CFTR): correlation between genotype and phenotypeHuman Genetics, 97
T. Dörk, M. Jr, F. Mekus, B. Tümmler, J. Tzountzouris, T. Casals, A. Krebsová, M. Koudova, I. Sakmaryová, M. Sr., V. Vávrová, D. Zemkova, E. Ginter, N. Petrova, T. Ivaschenko, V. Baranov, M. Witt, A. Pogorzelski, J. Bal, C. Zékanowsky, K. Wagner, M. Stuhrmann, I. Bauer, H. Seydewitz, T. Neumann, S. Jakubiczka, C. Kraus, B. Thamm, M. Nechiporenko, L. Livshits, N. Mossé, G. Tsukerman, L. Kádasi, M. Ravnik-Glavač, D. Glavač, R. Komel, K. Vouk, V. Kučinskas, A. Krūmiņa, M. Teder, S. Kocheva, G. Efremov, T. Onay, B. Kirdar, G. Malone, M. Schwarz, Z. Zhou, K. Friedman, S. Carles, M. Claustres, D. Bozon, C. Verlingue, C. Férec, M. Tzetis, E. Kanavakis, H. Cuppens, C. Bombieri, P. Pignatti, F. Sangiuolo, A. Jordanova, J. Kušic, D. Radojkovic, J. Sertić, D. Richter, A. Rukavina, E. Bjorck, B. Strandvik, H. Cardoso, M. Montgomery, B. Nakielna, D. Hughes, X. Estivill, I. Aznarez, E. Tullis, L. Tsui, J. Zieleński (2000)
Characterization of a novel 21-kb deletion, CFTRdele2,3(21 kb), in the CFTR gene: a cystic fibrosis mutation of Slavic origin common in Central and East EuropeHuman Genetics, 106
A. Anguiano, R. Oates, J. Amos, M. Dean, B. Gerrard, C. Stewart, T. Maher, M. White, A. Milunsky (1992)
Congenital bilateral absence of the vas deferens. A primarily genital form of cystic fibrosis.JAMA, 267 13
A. Vankeerberghen, Lin Wei, Hui Teng, M. Jaspers, J. Cassiman, B. Nilius, H. Cuppens (1998)
Characterization of mutations located in exon 18 of the CFTR geneFEBS Letters, 437
N. Rave-Harel, I. Madgar, R. Goshen, M. Nissim-Rafinia, A. Ziadni, A. Rahat, O. Chiba, Y. Kalman, C. Brautbar, D. Levinson (1995)
CFTR haplotype analysis reveals genetic heterogeneity in the etiology of congenital bilateral aplasia of the vas deferens.American journal of human genetics, 56 6
I. Ginjaar, A. Kneppers, Jan-Douwe Meulen, L. Anderson, M. Bremmer-Bout, J. Deutekom, J. Weegenaar, J. Dunnen, E. Bakker (2000)
Dystrophin nonsense mutation induces different levels of exon 29 skipping and leads to variable phenotypes within one BMD familyEuropean Journal of Human Genetics, 8
T. McCallum, J. Milunsky, R. Munarriz, R. Carson, H. Sadeghi-Nejad, R. Oates (2001)
Unilateral renal agenesis associated with congenital bilateral absence of the vas deferens: phenotypic findings and genetic considerations.Human reproduction, 16 2
T. Casals, L. Bassas, Susanna Egozcue, M. Ramos, J. Giménez, A. Segura, Ferrán García, M. Carrera, S. Larriba, J. Sàrquella, X. Estivill (2000)
Heterogeneity for mutations in the CFTR gene and clinical correlations in patients with congenital absence of the vas deferens.Human reproduction, 15 7
(2003)
Received on October
J. Wine (1992)
No CFTR: are CF symptoms milder?Nature Genetics, 1
T. Dörk, R. Fislage, T. Neumann, B. Wulf, B. Tümmler (2004)
Exon 9 of the CFTR gene: splice site haplotypes and cystic fibrosis mutationsHuman Genetics, 93
M. Claustres, C. Guittard, D. Bozon, F. Chevalier, C. Verlingue, C. Férec, E. Girodon, C. Cazeneuve, T. Bienvenu, G. Lalau, V. Dumur, D. Feldmann, E. Bieth, M. Blayau, C. Clavel, I. Creveaux, M. Malinge, N. Monnier, P. Malzac, H. Mittre, J. Chomel, J. Bonnefont, A. Iron, M. Chéry, M. Georges (2000)
Spectrum of CFTR mutations in cystic fibrosis and in congenital absence of the vas deferens in FranceHuman Mutation, 16
L. Su, C. Barnes, Weizhe Yao, Y. Qi, P. Lynch, G. Steinbach (2000)
Inactivation of germline mutant APC alleles by attenuated somatic mutations: a molecular genetic mechanism for attenuated familial adenomatous polyposis.American journal of human genetics, 67 3
P. Robinson (2001)
Cystic fibrosis
Zhenyuan Wang, J. Milunsky, M. Yamin, T. Maher, R. Oates, A. Milunsky (2002)
Analysis by mass spectrometry of 100 cystic fibrosis gene mutations in 92 patients with congenital bilateral absence of the vas deferens.Human reproduction, 17 8
M. Chillón, T. Casals, B. Mercier, L. Bassas, W. Lissens, S. Silber, M. Romey, Javier Ruiz-Romero, C. Verlingue, M. Claustres, V. Nunes, C. Férec, X. Estivill (1995)
Mutations in the cystic fibrosis gene in patients with congenital absence of the vas deferens.The New England journal of medicine, 332 22
P. Gasparini, G. Borgo, G. Mastella, A. Bonizzato, M. Dognini, P. Pignatti (1992)
Nine cystic fibrosis patients homozygous for the CFTR nonsense mutation R1162X have mild or moderate lung disease.Journal of Medical Genetics, 29
R. Gervais, V. Dumur, J. Rigot, J. Lafitte, P. Roussel, M. Claustres, J. Demaille (1993)
High frequency of the R117H cystic fibrosis mutation in patients with congenital absence of the vas deferens.The New England journal of medicine, 328 6
W. Lissens, K. Mahmoud, E. el-Gindi, A. Abdel-Sattar, S. Seneca, A. Steirteghem, I. Liebaers (1999)
Molecular analysis of the cystic fibrosis gene reveals a high frequency of the intron 8 splice variant 5T in Egyptian males with congenital bilateral absence of the vas deferens.Molecular human reproduction, 5 1
W. Highsmith, L. Burch, Zhaoqing Zhou, J. Olsen, T. Strong, Terry Smith, K. Friedman, L. Silverman, R. Boucher, F. Collins, M. Knowles (1997)
Identification of a splice site mutation (2789+5 G>A) associated with small amounts of normal CFTRmRNA and mild cystic fibrosisHuman Mutation, 9
D. Feldmann, J. Rochemaure, E. Plouvier, C. Magnier, C. Chauve, P. Aymard (1995)
Mild course of cystic fibrosis in an adult with the D1152H mutation.Clinical chemistry, 41 11
H. Morisaki, Takayuki Morisaki, L. Kristin, Newby, E. Holmes, Seymour Gray (1993)
Alternative splicing: a mechanism for phenotypic rescue of a common inherited defect.The Journal of clinical investigation, 91 5
(2001)
Novel, rare splice site variants of IVS8 in the cystic ®brosis gene
M. Dean, M. White, J. Amos, B. Gerrard, C. Stewart, K. Khaw, M. Leppert (1990)
Multiple mutations in highly conserved residues are found in mildly affected cystic fibrosis patientsCell, 61
W. Grody, G. Cutting, K. Klinger, C. Richards, M. Watson, R. Desnick (2001)
Laboratory standards and guidelines for population-based cystic fibrosis carrier screeningGenetics in Medicine, 3
V. Mak, K. Jarvi (1996)
The genetics of male infertility.The Journal of urology, 156 4
C. Scriver (2001)
The Metabolic and Molecular Bases of Inherited Disease, 8th Edition 2001Journal of Inherited Metabolic Disease, 24
V. Mak, V. Mak, K. Jarvi, K. Jarvi, J. Zieleński, P. Durie, Lap-Chee Tsui (1997)
Higher proportion of intact exon 9 CFTR mRNA in nasal epithelium compared with vas deferens.Human molecular genetics, 6 12
B. Kerem, O. Chiba-Falek, E. Kerem (1997)
Cystic fibrosis in Jews: frequency and mutation distribution.Genetic testing, 1 1
I. Lerer, Ayala Laufer‐Cahana, Jacob Rivlin, A. Augarten, D. Abeliovich (1999)
A large deletion mutation in the CFTR gene (3120+1Kbdel8.6Kb): A founder mutation in the Palestinian ArabsHuman Mutation, 13
H. Cuppens, Wei Lin, M. Jaspers, B. Costes, Hui Teng, A. Vankeerberghen, M. Jorissen, G. Droogmans, Ingrid Reynaert, M. Goossens, B. Nilius, J. Cassiman (1998)
Polyvariant mutant cystic fibrosis transmembrane conductance regulator genes. The polymorphic (Tg)m locus explains the partial penetrance of the T5 polymorphism as a disease mutation.The Journal of clinical investigation, 101 2
T. Dörk, T. Neumann, U. Wulbrand, B. Wulf, N. Kälin, Günter Maa, M. Krawczak, H. Guillermit, C. Férec, G. Horn, K. Klinger, B. Kerem, J. Zieleński, L. Tsui, B. Tümmler (1992)
Intra- and extragenic marker haplotypes of CFTR mutations in cystic fibrosis familiesHuman Genetics, 88
H. Teng, M. Jorissen, H. Poppel, E. Legius, J. Cassiman, H. Cuppens (1997)
Increased proportion of exon 9 alternatively spliced CFTR transcripts in vas deferens compared with nasal epithelial cells.Human molecular genetics, 6 1
P. Schlegel, D. Shin, M. Goldstein (1996)
Urogenital anomalies in men with congenital absence of the vas deferens.The Journal of urology, 155 5
M. Nikšić, M. Romano, E. Buratti, F. Pagani, F. Baralle (1999)
Functional analysis of cis-acting elements regulating the alternative splicing of human CFTR exon 9.Human molecular genetics, 8 13
E. Buratti, T. Dörk, Elisabetta Zuccato, F. Pagani, M. Romano, F. Baralle (2001)
Nuclear factor TDP‐43 and SR proteins promote in vitro and in vivo CFTR exon 9 skippingThe EMBO Journal, 20
J. Zieleński, P. Patrizio, M. Corey, B. Handelin, D. Markiewicz, Asch Rh, Lap-Chee Tsui (1995)
CFTR gene variant for patients with congenital absence of vas deferens.American journal of human genetics, 57 4
T. Onay, J. Zieleński, O. Topaloglu, N. Gokgoz, H. Kayserili, M. Apak, Y. Camcıoğlu, H. Çokuğraş, N. Akçakaya, L. Tsui, B. Kirdar (2001)
Cystic Fibrosis Mutation and Associated Haplotypes in Turkish Cystic Fibrosis PatientsHuman Biology, 73
BACKGROUND: Mutations of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) can cause congenital bilateral absence of the vas deferens (CBAVD) as a primarily genital form of cystic fibrosis. The spectrum and frequency of CFTR mutations in Turkish males with CBAVD is largely unknown. METHODS: We investigated 51 Turkish males who had been diagnosed with CBAVD at the Hacettepe University, Ankara, for the presence of CFTR gene mutations by direct sequencing of the coding region and exon/intron boundaries. RESULTS: We identified 27 different mutations on 72.5% of the investigated alleles. Two‐thirds of the patients harboured CFTR gene mutations on both chromosomes. Two predominant mutations, IVS8‐5T and D1152H, accounted for more than one‐third of the alleles. Five mutations are described for the first time. With one exception, all identified patients harboured at least one mutation of the missense or splicing type. Presently available mutation panels would have uncovered only 7–12% of CFTR alleles in this population cohort. CONCLUSIONS: Although cystic fibrosis is relatively rare in Turkey, CFTR mutations are responsible for the majority of CBAVD in Turkish males. Because of a specific mutation profile, a population‐specific panel should be recommended for targeted populations such as CBAVD in Turkey or elsewhere.
Human Reproduction – Oxford University Press
Published: May 1, 2004
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.